Artemis Investment Management LLP Bio Techne Corp Transaction History

Artemis Investment Management LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$71.62 - $86.62 $18.1 Million - $21.9 Million	-253,286 Reduced 52.98%	224,775 $16.7 Million
Q4 2022 Jan 25, 2023	BUY	$80.67 - $352.29 $28.5 Million - $124 Million	353,269 Added 283.09%	478,061 $0
Q3 2022 Oct 25, 2022	SELL	$282.54 - $391.85 $21 Million - $29.1 Million	-74,201 Reduced 37.29%	124,792 $35.5 Million
Q2 2022 Jul 22, 2022	SELL	$322.67 - $449.65 $4.65 Million - $6.49 Million	-14,423 Reduced 6.76%	198,993 $69.1 Million
Q1 2022 Apr 21, 2022	SELL	$353.85 - $487.79 $37.1 Million - $51.2 Million	-104,950 Reduced 32.97%	213,416 $92.3 Million
Q4 2021 Feb 08, 2022	BUY	$456.15 - $525.06 $5.95 Million - $6.85 Million	13,053 Added 4.28%	318,366 $165 Million
Q3 2021 Oct 26, 2021	BUY	$444.87 - $538.88 $10.9 Million - $13.1 Million	24,402 Added 8.69%	305,313 $148 Million
Q2 2021 Aug 04, 2021	BUY	$387.35 - $450.26 $62.3 Million - $72.4 Million	160,852 Added 133.98%	280,911 $127 Million
Q1 2021 Apr 28, 2021	BUY	$314.62 - $411.0 $37.8 Million - $49.3 Million	120,059 New	120,059 $45.8 Million

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

Stay updated on Artemis Investment Management LLP with notifications on news.